Former Executive Queried By U.S. Authorities In Ranbaxy Case
This article was originally published in PharmAsia News
Executive Summary
A senior employee of another drug maker, a former Ranbaxy Laboratories executive, reportedly resigned his most recent job after being detained and questioned by U.S. authorities. Neither employer would comment on the incident, but sources say the questioning involved the former executive's role in the U.S. investigation of alleged cases of fraudulent documentation and substandard production of drugs sent to the U.S. by Ranbaxy. The former Ranbaxy executive was said to have been the first questioned in the case. (Click here for more
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.